4
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Some Observations on Tax Policy for Pharmaceutical Research

Pages 77-88 | Published online: 28 Sep 2008

References

  • Forbes 24 April, 1995; 93
  • Various publications by IRS including: Credit for increasing research activities Code section 41(a) (1) (B) 4350 Research and experimental expenditures Code section 174 (a) (1) Headline 93 TNT 238–21 Costs of developing generic drugs are not eligible for research credit
  • Paraxel's Pharmaceutical R&D Statistical Sourcebook. Published by Paraxel International Corporation, Boston 1995

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.